ArticleOncotarget2017
MiR-1268b confers chemosensitivity in breast cancer by targeting ERBB2-mediated PI3K-AKT pathway.
Wen-Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2017
Wen-Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.